Rectal Cancer Study Produced Very Promising Treatment Results

In COVID-19, Latest News by Precision Vaccinations

The cure rate for nonmetastatic rectal cancer has been improving for decades but often includes unpleasant treatments, wrote Hanna K. Sanoff, M.D., M.P.H. in an Editorial published by The New England Journal of Medicine (NEJM) on June 5, 2022.
Recent phase 3 trial findings have increased treatment intensity to include multiagent chemotherapy in addition to radiation therapy before proctectomy is performed.
Such treatment has resulted in a 3-year disease-free survival rate of up to 77%.

Read More